MAELYN DISHMAN: Open Payments
NPI 1740520436 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$634 in 26 payments from 14 companies in 2025. Trend: 2023 $563 · 2024 $1,017 · 2025 $634
Food & beverage: $634
| Company | Payments | Amount |
|---|---|---|
| Endo USA, Inc. | 4 | $107 |
| Astellas Pharma US Inc | 4 | $104 |
| Boston Scientific Corporation | 2 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| Dendreon Pharmaceuticals LLC | 2 | $57 |
| Antares Pharma, Inc. | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| UROGEN PHARMA, INC. | 1 | $27 |
| Teleflex LLC | 1 | $26 |
| Laborie Medical Technologies Corp. | 1 | $25 |
Products named: XIAFLEX, Xtandi, Nubeqa, PROVENGE, SpaceOAR VUE System - 10mL, XYOSTED, PLUVICTO, BARRIGEL.
Industry payments across TX — which companies pay providers there.
